| 临床试验中进行药物经济评价存在的问题 |
| |
| 引用本文： | 吴晶,黄泰康.临床试验中进行药物经济评价存在的问题[J].中国新药杂志,2006,15(10):753-756. |
| |
| 作者姓名： | 吴晶 黄泰康 |
| |
| 作者单位： | 1. 沈阳药科大学社会药学研究中心,沈阳,110016;北京大学中国医药经济研究中心,北京,100871
2. 沈阳药科大学社会药学研究中心,沈阳,110016 |
| |
| 摘 要： | 药物经济评价的快速发展源于社会对有效利用药物资源的迫切需求.随着在临床试验中进行平行药物经济评价经验的增加,探索在临床试验中收集药物经济评价数据的优缺点,为进行药物经济评价寻找最佳收集数据的试验条件具有重要意义.现回顾和综述前人收集药物经济评价数据中存在的问题,总结在临床试验中进行药物经济评价的经验,为合理的药物经济数据收集条件提出建议.
|
| 关 键 词： | 药物经济学 成本-效果 临床试验 健康产出 |
| 文章编号： | 1003-3734（2006）10-0753-04 |
| 修稿时间： | 2005-12-02 |
Pharmacoeconomic evaluation in drug clinical trials |
| |
| WU Jing,HUANG Tai-kang.Pharmacoeconomic evaluation in drug clinical trials[J].Chinese Journal of New Drugs,2006,15(10):753-756. |
| |
| Authors: | WU Jing HUANG Tai-kang |
| |
| Institution: | 1 Center for Modern Social Pharmacy Research, Shenyang Pharmaceutical University, Shenyang 110016, China ; 2 Center for Pharmacoeconomics and Outcomes Research, Peking University, Beijing 100871, China |
| |
| Abstract: | Studies of pharmacoeconomic evaluation are conducted in accordance with the specific needs of the optimal use of drug scarce resources to help minimise costs and maximise benefits. These studies used clinical trial data not only to develop appropriate models to determine clinical outcomes and costs in hypothetical cohorts of patients, but also to gather actionable data to help develop and promote optimal clinical trials. This article reviews pro and con of pharmoeconomics used for data collections in clinical trials. The strategies of pharmaeconomics in the data collections were discussed. |
| |
| Keywords: | pharmacoeconomics cost-effectiveness clinical trials health outcome |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
